Lymnaea stagnalis Putative neurotrophin receptor LTRK 1-Yeast

Basic informations

  • Size: 1000ug
  • Catalog number: GEN1045119.Yeast
  • Price: 2603.00EUR
Lymnaea stagnalis Putative neurotrophin receptor LTRK 1-Yeast

Long name

Recombinant Lymnaea stagnalis Putative neurotrophin receptor LTRK 1

Alternative names

Putative neurotrophin receptor LTRK 1; Putative neurotrophin receptor LTRK 1;

Gene name

N/A

General description

Putative neurotrophin receptor LTRK 1 is a recombinant protein expressed in Yeast . The protein can be with or without a His-Tag or other tag in accordance to customer's request. All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility.

Product category

Recombinant Proteins

Expression system

Yeast

Available also expressed in:

E Coli ; Yeast ; Baculovirus ; Mammalian Cell

Purity

Greater than 90% (determined by SDS-PAGE)

Form

Lyophilized protein

Storage

This protein can be stored at -20 degrees Celsius. For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius. Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains.

Applications

This protein can be used as a positive control for applications such as ELISA, IFA, RIA, Western Blot, etc.

Description

The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.